Fairvalue-Calculator Fairvalue-Calculator
EN DE

Quanterix Corporation (QTRX) Fair Value & Analysis

Healthcare · US · Market cap $164M

Price$3.78
Fair Value$1.89
Upside-50.0%
Quality95/100
Evidence: Low Range $1.25 – $2.37

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Quanterix Corporation (QTRX) currently trades at $3.78, while our model-based Fair Value estimate is $1.89 — implying the stock looks roughly 50.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation. It sells its products for the life science res…

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -81% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Quanterix Corporation (QTRX) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $1.89 versus a price of $3.78 — about −50% (overvalued). Model-based estimate, not financial advice.
What is the fair value of QTRX?
Our 21-model fair value for Quanterix Corporation is $1.89 (as of Jun 25, 2026), built from audited fundamentals. The current price is $3.78.
What is the quality score of QTRX?
Quanterix Corporation has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.